{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:24:08Z","timestamp":1787311448596,"version":"build-2736575974"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.cld.2026.04.008","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T22:26:29Z","timestamp":1780957589000},"page":"751-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cOverlap\u201d Syndromes in Autoimmune Liver Disease"],"prefix":"10.1016","volume":"30","author":[{"given":"Roie","family":"Tzadok","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inbal","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cld.2026.04.008_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/j.1365-2036.2012.05223.x","article-title":"Review article: overlap syndromes and autoimmune liver disease","volume":"36","author":"Trivedi","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"10.1016\/j.cld.2026.04.008_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.cld.2026.04.008_bib3","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.autrev.2010.09.024","article-title":"Autoimmune hepatitis, HLA and extended haplotypes","volume":"10","author":"Oliveira","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/gut.2006.111864","article-title":"Autoimmune hepatitis triggered by hepatitis A","volume":"56","author":"Singh","year":"2007","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.cld.2026.04.008_bib5","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.4049\/jimmunol.162.3.1802","article-title":"Mimicry between the hepatitis B virus DNA polymerase and the antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis B virus infection","volume":"162","author":"Gregorio","year":"1999","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib6","first-page":"326","article-title":"The overlap syndromes of autoimmune hepatitis","volume":"58","author":"Czaja","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","article-title":"Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue","volume":"54","author":"Boberg","year":"2011","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.cld.2026.04.008_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000123","article-title":"Immune signatures in variant syndromes of primary biliary cholangitis and autoimmune hepatitis","volume":"7","author":"Schulthei\u00df","year":"2023","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2026.04.008_bib9","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12967-024-05029-6","article-title":"Multi-omics approaches for drug-response characterization in primary biliary cholangitis and autoimmune hepatitis variant syndrome","volume":"22","author":"Yang","year":"2024","journal-title":"J Transl Med"},{"issue":"5","key":"10.1016\/j.cld.2026.04.008_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051449","article-title":"Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis","volume":"9","author":"Freedman","year":"2020","journal-title":"J Clin Med"},{"issue":"7","key":"10.1016\/j.cld.2026.04.008_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1155\/2013\/198070","article-title":"Diagnosis and management of the overlap syndromes of autoimmune hepatitis","volume":"27","author":"Czaja","year":"2013","journal-title":"Can J Gastroenterol"},{"issue":"7","key":"10.1016\/j.cld.2026.04.008_bib12","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.cgh.2011.03.019","article-title":"Prevalence of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome","volume":"9","author":"Bonder","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib13","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"issue":"Suppl 2","key":"10.1016\/j.cld.2026.04.008_bib14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000440831","article-title":"Overlap syndromes","volume":"33","author":"Chazouill\u00e8res","year":"2015","journal-title":"Dig Dis"},{"issue":"10003","key":"10.1016\/j.cld.2026.04.008_bib15","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.cld.2026.04.008_bib16","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.3748\/wjg.14.3368","article-title":"Overlap syndromes among autoimmune liver diseases","volume":"14","author":"Rust","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.008_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.21037\/tgh-24-140","article-title":"Overlap syndromes in autoimmune liver disease: a review","volume":"10","author":"Sohal","year":"2025","journal-title":"Transl Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouill\u00e8res","year":"1998","journal-title":"Hepatology"},{"issue":"22","key":"10.1016\/j.cld.2026.04.008_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12227047","article-title":"Primary biliary cholangitis (PBC)-Autoimmune Hepatitis (AIH) variant syndrome: clinical features, response to therapy and long-term outcome","volume":"12","author":"Graf","year":"2023","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib20","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ajg.2017.440","article-title":"Major hepatic complications in ursodeoxycholic acid-treated patients with primary biliary cholangitis: risk factors and time trends in incidence and outcome","volume":"113","author":"Harms","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cld.2026.04.008_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1740-2557-4-3","article-title":"The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis\/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders","volume":"4","author":"Papamichalis","year":"2007","journal-title":"J Autoimmune Dis"},{"issue":"3","key":"10.1016\/j.cld.2026.04.008_bib22","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/hep4.1148","article-title":"New scoring classification for primary biliary cholangitis-autoimmune hepatitis overlap syndrome","volume":"2","author":"Zhang","year":"2018","journal-title":"Hepatol Commun"},{"issue":"1","key":"10.1016\/j.cld.2026.04.008_bib23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/MOG.0000000000001149","article-title":"PBC-AIH variant syndrome: emerging new terminology and a new approach to diagnosis and management","volume":"42","author":"Sebode","year":"2026","journal-title":"Curr Opin Gastroenterol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib26","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.jhep.2025.03.017","article-title":"EASL clinical practice guidelines on the management of autoimmune hepatitis","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.cld.2026.04.008_bib28","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"issue":"6","key":"10.1016\/j.cld.2026.04.008_bib29","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.cld.2026.04.008_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL Clinical Practice Guidelines: Autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib31","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2036.2008.03722.x","article-title":"Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival","volume":"28","author":"Al-Chalabi","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib32","article-title":"Biliary disease progression in childhood onset autoimmune liver disease: a 30-year follow-up into adulthood","volume":"6","author":"Warner","year":"2024","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib33","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jhep.2023.02.030","article-title":"Primary sclerosing cholangitis and overlap features of autoimmune hepatitis: a coming of age or an age-ist problem?","volume":"79","author":"Ricciuto","year":"2023","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.cld.2026.04.008_bib34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL clinical practice guidelines: management of cholestatic liver diseases","volume":"51","year":"2009","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.008_bib35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cld.2022.06.007","article-title":"The inconvenient truth of primary biliary cholangitis\/autoimmune hepatitis overlap syndrome","volume":"26","author":"Hussain","year":"2022","journal-title":"Clin Liver Dis"},{"issue":"5","key":"10.1016\/j.cld.2026.04.008_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2025.100728","article-title":"Integrating molecular testing with clinical criteria and histopathology improves diagnostic precision in immune-mediated liver diseases","volume":"38","author":"Arroyave","year":"2025","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.cld.2026.04.008_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26051863","article-title":"A closer look into autoimmune liver diseases","volume":"26","author":"Filipovic","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.cld.2026.04.008_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.966329","article-title":"Artificial intelligence for precision medicine in autoimmune liver disease","volume":"13","author":"Gerussi","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.cld.2026.04.008_bib39","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJMoa2312100","article-title":"A phase 3 trial of seladelpar in primary biliary cholangitis","volume":"390","author":"Hirschfield","year":"2024","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.cld.2026.04.008_bib40","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa2306185","article-title":"Efficacy and safety of elafibranor in primary biliary cholangitis","volume":"390","author":"Kowdley","year":"2024","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.cld.2026.04.008_bib41","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2017.05.009","article-title":"norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis","volume":"67","author":"Fickert","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.008_bib42","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2468-1253(25)00208-0","article-title":"Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trial","volume":"11","author":"Trauner","year":"2026","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.cld.2026.04.008_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jhep.2025.04.025","article-title":"Safety and efficacy of elafibranor in primary sclerosing cholangitis: the ELMWOOD phase II randomized-controlled trial","volume":"84","author":"Levy","year":"2026","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.cld.2026.04.008_bib44","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.jhep.2021.12.041","article-title":"Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group","volume":"76","author":"Pape","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2026.04.008_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102565","article-title":"Unmet needs in autoimmune liver diseases","volume":"95","author":"Kolev","year":"2025","journal-title":"Curr Opin Immunol"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326126000425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:34:41Z","timestamp":1784763281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326126000425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1089326126000425"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cOverlap\u201d Syndromes in Autoimmune Liver Disease","name":"articletitle","label":"Article Title"},{"value":"Clinics in Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cld.2026.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}